Meihua International Medical Technologies (MHUA) shares plunged 43% after the company reported late Friday that it received a delisting notice from Nasdaq for failing to meet the $1 minimum bid price requirement.

Intraday trading volume jumped to over 89,000 from a daily average of about 7,000.

BiomX (PHGE) reported Monday a discontinuation of a phase 2b clinical trial of nebulized phage therapy, BX004, in patients with CF associated with chronic Pseudomonas aeruginosa infections.

After assessing the Data Monitoring Committee feedback and an internal analysis of unexpectedly high rates of adverse events, the company said it has elected to discontinue the trial.

Shares of the company slumped 27% as intraday trading volume climbed to over 713,000 from a daily average of about 53,000.

Air Products (APD) is in talks with Yara International to collaborate on low-emission ammonia projects in Louisiana and Saudi Arabia, the companies said Monday.

Shares fell 9% as intraday trading volume soared to more than 2.06 million from a daily average of roughly 1.23 million.

Price: 7.72, Change: -6.30, Percent Change: -44.91